In State of the Union Week, Pressure Only Rising for PBM Reform
NACDS President and CEO Steven C. Anderson issued a statement in advance of President Biden’s speech.
NACDS President and CEO Steven C. Anderson issued a statement in advance of President Biden’s speech.
“It is imperative that Congress enact these reforms soon in the 118th Congress. We stand ready to support that effort because if ever there were must-pass legislation, PBM reforms in Medicare and Medicaid are it.”
NACDS letter to President Biden urges Executive Branch action and support of immediate Congressional action on PBM reforms; comes in advance of White House listening session on reforms to address harmful PBM tactics.
"We appreciate the leadership and hard work that have gone into the many bipartisan PBM reform legislative efforts this congress. We reiterate that these reforms are needed without delay."
The 2024 Conference — “Within Reach” — is being held February 11-13 in Bonita Springs, FL, and is the kick-off of NACDS meetings and conferences this year.
“Americans deserve and expect protection from inflated prescription drug costs, from forced pharmacy closures, and from barriers to their pharmacy of choice that result from PBM tactics”
PBM reform, access to pharmacist services, and value-based care are among the recommendations to the Health Subcommittee of the House Energy and Commerce Committee.
NACDS is applauding the Senators for sending a letter urging the Federal Trade Commission to “complete its investigation into the health care industry’s most powerful prescription drug middlemen.”
Employers moving on from dominant PBMs to save costs demonstrates the need for Congress to stand up for Medicare and Medicaid, too.
NACDS continues to urge the U.S. Congress to finish the job – and enact the bipartisan PBM reforms that Congress has advanced in the 118th Congress. A January 19 Inside Health Policy article quotes NACDS on the topic.